Self-balancing exoskeleton wins broader FDA clearance to help more people walk

For many people with paralysis or severe mobility loss, standing upright and walking again can seem out of reach. Robotic exoskeletons aim to change that, but most require the user to grip crutches or a walker for balance, putting them beyond the reach of those with limited upper-body strength. On November 6, 2025, The Robot Report covered a step forward: Wandercraft's Atalante X, a self-balancing exoskeleton, earned its second U.S. Food and Drug Administration clearance, widening who can use it.

The Atalante X is unusual because it balances itself, letting the wearer walk hands-free without canes or crutches. The expanded clearance authorizes its use for people with spinal cord injuries ranging from the C4 to L5 levels, a broader range than its earlier T5-to-L5 indication, and for people with multiple sclerosis. CEO Matthieu Masselin said the system helps personalize training for complex patients and lets those with severely limited upper-body strength experience upright movement safely. A multicenter study of 547 training sessions reported safe use in people with high-level spinal cord injuries, with encouraging functional improvements.

“Robotic exoskeletons aim to change that, but most require the user to grip crutches or a walker for balance, putting them beyond the reach of those with limited upper-body strength.”

Why it matters reaches beyond walking itself. Regular upright movement and gait therapy can support circulation, bone health, muscle activity and mental well-being, and the dignity of standing and moving on one's own terms is profound. By serving people with higher-level injuries and additional conditions, the broader clearance opens this technology to more of those who could benefit, across the 100-plus rehabilitation centers where Wandercraft already operates.

The honest caveats are worth noting. A self-balancing exoskeleton is a clinical rehabilitation tool used under supervision, not yet an everyday personal mobility device for the home, and such systems remain costly and complex. Access depends on clinics, training and reimbursement. Even so, a robot that lets people with severe paralysis stand and walk hands-free, now cleared for more conditions, is exactly the kind of human-centered engineering that restores both function and dignity. As the technology matures, it could help many more people experience the simple, powerful act of walking again.